Blood · 2003 · 260 citations · 23 references
Life SciencesGeneticsMolecular BiologyGene ExpressionMolecular OncologyTranscriptional RegulationGene Expression RegulationGene SilencingRna InterferenceSmall Interfering Rna BiologyTranscriptional ControlBcr-abl InhibitorsBcr-abl1 Fusion GeneRna Interference-mediated SuppressionShort Interfering Rna TherapySmall Interfering Rna ChemistrySmall Interfering Rna FunctionTherapeutic Small Interfering Rna
Small interfering RNAs (siRNAs) were designed to target the bcr-abl oncogene, which causes chronic myeloid leukemia (CML) and bcr-abl-positive acute lymphoblastic leukemia (ALL). Chemically synthesized anti-bcr-abl siRNAs were selected using reporter gene constructs and were found to reduce bcr-abl mRNA up to 87% in bcr-abl-positive cell lines and in primary cells from CML patients. This mRNA reduction was specific for bcr-abl because c-abl and c-bcr mRNA levels remained unaffected. Furthermore, protein expression of BCR-ABL and of laminA/C was reduced by specific siRNAs up to 80% in bcr-abl-positive and normal CD34(+) cells, respectively. Finally, anti-bcr-abl siRNA inhibited BCR-ABL-dependent, but not cytokine-dependent, proliferation in a bcr-abl-positive cell line. These data demonstrate that siRNA can specifically and efficiently interfere with the expression of an oncogenic fusion gene in hematopoietic cells.
23
Role for a bidentate ribonuclease in the initiation step of RNA interference
Emily Bernstein, Amy A. Caudy, Scott M. Hammond et al. · Nature · 2001 · 4.9K citations
An RNA-directed nuclease mediates post-transcriptional gene silencing in Drosophila cells
Scott M. Hammond, Emily Bernstein, David Beach et al. · Nature · 2000 · 3K citations